CSBR
Champions Oncology Inc
4.90$
-1.0%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 57.2% | 65.3% | 51.8% | 50.3% | 55.1% | 38.8% | 58.9% | 57.1% | 48.3% | 53.3% | 49.2% | 51.5% | 50.7% | |
| 42.8% | 34.7% | 48.2% | 49.7% | 44.9% | 61.2% | 41.1% | 42.9% | 51.7% | 46.7% | 50.8% | 48.5% | 49.3% | |
| 21.7% | 18.2% | 14.6% | 10.3% | 12.5% | 10.1% | 15.9% | 14.9% | 17.4% | 13.7% | 15.3% | 15.4% | 15.4% | |
| 22.5% | 23.0% | 19.7% | 18.0% | 14.0% | 14.1% | 20.4% | 18.4% | 19.8% | 18.0% | 19.0% | 17.5% | 18.6% | |
| 59.7% | 56.1% | 50.2% | 40.3% | 39.5% | 34.8% | 55.0% | 46.5% | 50.5% | 47.8% | 55.3% | 51.2% | 51.0% | |
| -16.9% | -21.4% | -1.9% | 9.5% | 5.4% | 26.4% | -13.9% | -3.6% | 1.2% | -1.1% | -4.6% | -2.7% | -1.7% | |
| -17.8% | -21.0% | -1.4% | 9.5% | 5.5% | 26.5% | -15.9% | -3.2% | 1.7% | -1.4% | -3.6% | -2.7% | -1.5% | |
| 0.1% | 0.1% | -0.6% | 0.1% | 0.1% | 0.1% | -1.0% | 0.1% | 0.1% | 0.3% | 1.2% | 0.1% | 0.4% | |
| -17.9% | -21.1% | -0.8% | 9.3% | 5.4% | 26.4% | -14.9% | -3.3% | 2.0% | -1.7% | -5.3% | -2.8% | -1.9% | |
| -13.6% | -17.0% | 4.4% | 12.7% | 8.4% | 28.9% | -12.7% | -0.7% | 4.1% | 0.6% | -1.3% | -0.6% | 0.7% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.